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The term ‘newborn screening’ generally describes various
tests that can occur during the first few hours or days of a
newborn’s life. These screening tests have the potential for
preventing catastrophic health outcomes to newborns and
their family when they are properly timed and performed.
Newborn dried bloodspot screening (NDBS) is one type ofentre (General Organization), Saudi Arabia. Production and hosting
icense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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placed onto special absorbent paper, air dried, and trans-
ported to a screening laboratory for analysis. The presence
of abnormal concentrations of certain biochemical markers
can indicate increased risks for the condition of interest
and must be confirmed through further diagnostic testing.
Other types of NBS include hearing loss and congenital
heart defects, among others, but this manuscript focuses
on NDBS screening.
To provide national uniformity and equality, NDBS pro-
grams are generally part of the national public health
prevention system. While in their initial phase, NDBS pro-
grams may exist in academic or private settings, and their
institutionalization and sustainability at the national level
require recognition by the health ministry and integration
into the public health system. This recognition can take
different forms in different settings ranging from simple
recognition statements to full-scale program implementa-
tion and support. Although government financing is ideal
and assures sustainability, there are successful programs in
which full or partial payment is made by the family
obtaining the screening service.
NDBS programs function within a comprehensive system
that includes education, screening, short-term follow-up,
diagnosis, treatment/management, and long-term follow-
up/evaluation [1]. The NDBS system is often challenged by
economic, political, and cultural considerations. The initi-
ation of NBS in developing health systems, such as many in
the Middle East and North Africa (MENA) and the Asia Pacific
(AP) regions, has been slow for various reasons, including
lack of understanding by the individual as well as family,
societal, and financial benefits. All countries with NDBS
either have faced or will face challenges in implementing
NBS; however, many developing health systems face addi-
tional challenges related to the economy, government
stability, culture/religion, geography, and health/political
priorities [2e6].
The countries in the MENA and AP regions vary widely in
size from small countries (e.g., Bahrain, Lebanon, Qatar,
Kuwait, New Zealand, and Singapore) to large countries
(e.g., Saudi Arabia, Egypt, Iran, Libya, Algeria, China, and
Mongolia). Some countries are economically advanced
(e.g., Saudi Arabia, United Arab Emirates, Qatar, Kuwait,
Australia, Japan, New Zealand, and Singapore), whereas
others are economically developing (e.g., Iraq, Iran, Syria,
Jordan, Morocco, Libya, Algeria, Yemen, Philippines,
Indonesia, Sri Lanka, and Vietnam). Out-of-hospital births
remain a challenge in Bangladesh (80%), India (61%),
Philippines (62%), Pakistan (80%), Laos (85.7%), Iran
(34.4%), Palestine (38.8%) and Yemen (50%) [3,4,6]. Written
languages that use character sets not readily understood by
outsiders (e.g., Arabic, Chinese, and Thai) also present
special challenges, particularly to experts on developed
programs who cannot easily communicate their experiences
or share educational materials. Despite these variabilities
and challenges, NDBS champions continue to press for
progress in the more progressive developing health systems
in both regions [2e6].
Historically, successful NDBS has developed from the
efforts of an interested individual or group of individuals
concerned with improving the health outcomes for new-
borns and their families. In limited cases (usually in smallcountries, such as Singapore and Hong Kong), the NDBS
program has developed as a government service. How-
ever, academic and hospital initiatives have become
more common. Without recognition of the importance of
NDBS by the health ministry, these initiatives have often
remained isolated and have exhibited slow progress.
Their institutionalization at the national level invariably
requires intersection with government public health ac-
tivities. Sometimes, these efforts have taken years to
develop into a comprehensive system that adequately
serves all newborns. Success in the development and
institutionalization of NDBS has typically resulted from
the perseverance of dedicated leaders who work to gain
the required expertise in NDBS medical and laboratory
science and whose perseverance results in overcoming
the political, cultural and economic challenges [7].
Through our efforts in working with individuals and
groups seeking to begin and improve NDBS in both devel-
oped and developing health systems, we have identified
four strategic elements useful for developing a successful
and sustainable NDBS program. These include the
following: (1) identifying and nurturing strong leadership
with the goal of educating others, designing and carrying
out pilot studies to obtain data for health policy develop-
ment, and gathering program support from potential
stakeholders (parents, professionals, and policymakers);
(2) initiating strategic advocacy initiatives targeted at
providing policymakers, health professionals and the gen-
eral public with a basic understanding of the operation and
value of NDBS; (3) developing and maintaining strong col-
laborations between NDBS stakeholder groups (government
organizations, non-government organizations, and in-
dividuals) in planning and implementation; and (4) devel-
oping innovative and sustainable financing strategies.
In this manuscript, we briefly summarize the current
status of NBS efforts in a large part of the developing world
(MENA and AP), review some of the challenges associated
with implementing and sustaining NDBS in a developing
healthcare environment, and discuss some example ap-
proaches and experiences in overcoming internal barriers
to NBS implementation. Whenever possible, we provide
examples of successful NDBS program activities, acknowl-
edging that there are many other examples of success that
are not noted here.
2. Screening in the Middle East/North Africa
and the Asia Pacific regions
Table 1 summarizes selected demographic data for the
countries in the MENA and AP regions with developing NDBS
systems. These data are the latest available from the World
Health Organization (WHO) and provide comparisons of
population totals, annual births, gross national income,
fertility rates, infant mortality rates and percentages of
government budgets allocated for health [8e10]. A sum-
mary of published NDBS screening data in the two regions is
also given. Accurate data from developing programs are
sparse, and the data listed may not be current, particularly
that for MENA [2e4,6].
It is interesting to compare the percentages of govern-
ment expenditures for health in 2000 and 2008 because this
Table 1 Selected demographics for countries with developing NDBS programs in MENA and AP regions.
Country Total population
(thousands)a
Annual births
(thousands)a
Infant mortality
(per 1000 live
births)a
GNI per
capita
(US$)a,b
Total
fertility
ratec
% Central government
expenditures expended
on healthd
Percentage of
newborns
screened annuallye
2011 2011 1990 2011 2011 2011 2000 2008
Middle East and North Africa
Algeria 35,980 712 54 26 4470 2 9.0 10.6 e
Bahrain 1324 23 18 9 15,920 3 10.2 10.3 e
Egypt 82,537 1886 63 18 2600 3 7.5 5.9 94.4
Iran (Islamic
Republic of)
74799 1255 47 21 4520 2 8.4 8.7 84.4
Iraq 32,665 1144 37 31 2640 5 1.3 3.1 e
Jordan 6330 154 31 18 4380 3 11.0 16.3 e
Kuwait 2818 50 14 9 48,900 2 5.5 6.1 e
Lebanon 4259 65 27 8 9110 2 8.0 12.3 31.4
Libyan Arab
Jamahiriya
6423 144 33 13 12,320 3 6.0 5.5 e
Morocco 32,273 620 64 28 2970 2 4.0 6.6 e
Occupied
Palestinian
Territory
4147 148 e 24 1230 5 e e e
Oman 2846 50 36 7 19,260 2 7.1 4.9 98.9
Qatar 1870 21 17 6 80,440 2 5.0 6.8 100.0
Saudi Arabia 28,083 605 34 8 17,820 3 9.2 8.4 13.7
Syrian Arab
Republic
20,766 466 30 13 2750 3 6.5 4.6 e
Tunisia 10,594 179 40 14 4070 2 8.1 10.4 e
United Arab
Emirates
7891 94 19 6 40,760 2 7.6 8.9 100.0
Yemen 24,800 940 89 57 1070 5 8.3 4.3 e
East Asia and the Pacific
Cambodia 14,305 317 85 36 830 3 8.7 9.0 e
China 1,347,565 16,364 39 13 4930 2 11.1 10.3 w59
Indonesia 242,326 4331 54 25 2940 2 4.5 6.2 <1
Korea (North) e No data available e
Lao People’s
Democratic
Republic
6288 140 102 34 1130 3 5.1 3.7 w7
Malaysia 28,859 579 15 6 8420 3 6.2 6.9 >95f
Mongolia 2800 65 76 26 2320 2 10.7 7.5 w6
Nepal 30,486 722 94 39 540 3 7.7 11.3 e
Palau 21 <1 27 14 7250 e 12.0 16.6 >70
Philippines 94,852 2358 40 20 2210 3 7.0 6.1 w28
Vietnam 88,792 1458 36 17 1260 2 6.6 9.3 w7
South Asia
Bangladesh 150,494 3016 97 37 770 2 7.6 7.4 <5
India 1,241,492 27,098 81 47 1410 3 3.9 4.4 <1
Pakistan 176,745 4764 95 59 1120 3 2.3 3.1 <1
Sri Lanka 21,045 373 24 11 2580 2 6.9 7.9 w3
a The data are from Ref. [8] with the exception of the data for Occupied Palestinian Territory, which were obtained from Ref. [9].
b GNI per capita e The gross national income (GNI) is the sum of value added by all resident producers plus any product taxes (less
subsidies) not included in the valuation of output and any net receipts of primary income (compensation of employees and property
income) from abroad. The GNI per capita is the gross national income divided by the midyear population. The GNI per capita in US dollars
is converted using the World Bank Atlas method Ref. [8].
c Total fertility rate e Number of children who would be born per woman if she lived to the end of her childbearing years and bore
children at each age in accordance with prevailing age-specific fertility rates Ref. [8].
d The data are from Ref. [10].
e The data for MENA countries are from Refs. [2,3], and the data for Asia Pacific countries were obtained from Refs. [4,6].
f The percentage of infants screened refers to G6PD only, as reported in Ref. [6]; the extent of coverage for congenital hypothyroidism
is not known.
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tential for supporting a new program, such as NDBS. The
infant mortality rates (IMR) in 1990 and 2011 are provided
to emphasize the trends and improvements over time
across the two regions and to emphasize the growing
importance of establishing NDBS as a public health pre-
vention program. The March of Dimes’ Global Report on
Birth Defects notes that genetic and congenital conditions
are increasingly important in the overall public health
impact once the infant mortality falls below 50 per 1000
births [11]. There have been significant improvements in
the infant mortality rates in the MENA and AP regions over
the past two decades. With the exception of Yemen and
Pakistan, all of the countries in these two regions reported
infant mortality rates in 2011 that were lower than 50/1000
births.
In the MENA region, larger percentages of consan-
guineous marriages are known to contribute to an
increased number of problematic genetic conditions in
newborns [12e15]. For this reason, it may be argued that
NDBS for inborn errors in the metabolism is more impor-
tant in MENA than in many other parts of the world.
Previous NDBS data from the MENA region and recent pilot
NDBS studies in Bahrain and Oman tend to confirm this
argument [2,16,17]. Similarly, screening for congenital
hypothyroidism is generally accepted to be a universal
problem that affects approximately 1:2500 newborns
worldwide, with higher prevalence in iodine-deficient
areas, which exist within MENA and AP [7]. Certain he-
moglobin disorders, such as thalassemias and glucose-6-
phosphate dehydrogenase (G6PD) deficiency, are also
present in many parts of both regions, and sickle cell
anemia is even found in some locations [18e22]. Thus,
the consideration of NDBS programs for multiple condi-
tions (sometimes called ‘expanded screening’) is
increasingly important.
For the development of a new NDBS programs, it is
critical to gain knowledge from developed programs and
to be aware of successful development strategies in
neighboring countries. Thus, several knowledge-sharing
conferences and implementation workshops have been
conducted in both the MENA and AP regions. These con-
ferences have provided opportunities to develop com-
munications networks within the two regions and to learn
from international experts, who provide a knowledgebase
on which to build stronger program infrastructures. The
results of some of these meetings have been published,
and other reports are in development [3,6]. Three MENA
regional meetings have been held in Marrakech, Morocco
(2006), Cairo, Egypt (2008) and Doha, Qatar (2011). A
fourth is being organized as a collaboration between local
NDBS advocates and the International Society for
Neonatal Screening (ISNS) but a date and location have
not yet been determined. The first three meetings were
primarily supported with funding from the U.S. National
Institutes of Health (NIH) and, as such, included signifi-
cant emphasis on possible research initiatives that may
assist in NDBS program development (research is the
primary mission of NIH). Workshops were also part of the
conferences and focused on local NDBS program devel-
opment and quality improvement with country progress
reports and goal setting as the primary discussions.The AP meetings were organized under slightly different
circumstances. Building on previous regional conferences as
part of an International Atomic Energy Agency (IAEA)
project, the Philippine Newborn Screening Reference Cen-
ter took the lead in organizing a continuing string of con-
ferences/workshops for NDBS programs within the AP with
national coverages of less than 50% of all newborns. Fund-
ing support was obtained from both commercial and non-
commercial sources. To date, there have been four regional
NDBS meetings: Cebu, Philippines (2008), Manila,
Philippines (2010 and 2012), and Cebu, Philippines (2013).
The conference attendees requested and received official
acknowledgment as a working group of the Asia Pacific
Society of Human Genetics. As with MENA, these meetings
have included experts from developed screening programs
and representatives from national screening projects and
health ministries within the AP region. The programs have
focused on identifying and overcoming internal barriers to
national NDBS program implementation, infrastructure
development and quality assurance. Continuous reviews/
updates of each country’s NDBS ‘plan of action’ are avail-
able. Future meetings are anticipated at approximately
two-year intervals.
Participants from 18 MENA countries at the first MENA
conference developed an output document, the ‘Marra-
kech Declaration,’ noting that, “Newborn screening is an
important tool in the prevention of disease and disability
in our children and thus should be a key part of a
comprehensive public health system in all of our coun-
tries.” To emphasize the importance of NBS to health
ministry officials and other stakeholders, the conference
participants recommended that “. all countries in the
region should screen for at least one condition and
develop a national model program that takes into account
all aspects for post-testing care.” [3] At the first AP
conference, the participants from 11 countries developed
the ‘Cebu Declaration’ as an output document with a
similar intent [6]. Despite the relatively simple goal of
screening one condition in each country, many of the low-
and middle-income countries in each region still face
significant implementation challenges, particularly in
countries in which health systems are stressed.
3. Challenges associated with implementing
NDBS in a developing healthcare system
Experiences in the implementation of successful NDBS
programs in both developed and developing healthcare
systems appear to focus on addressing the following ten
challenges to successfully implement a sustainable NDBS
program:
(1) Planning e NDBS momentum is created through
visionary ideas that can be molded into a systematic
approach to a sustainable national NDBS program.
Once logically developed, the program plan provides
a foundation on which to establish the other elements
necessary for success.
(2) Leadership e Successful program implementation
usually requires passionate leadership (individual or
group) with an ability to understand and address
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successfully motivate others. The initiation of a new
program or new ideas usually requires time, and
leaders must be willing to make the required time
investment.
(3) Education e New ideas result from the accumula-
tion and transfer of new knowledge. The education
of professionals, policymakers and the public must
be provided in a carefully thought-out way that
addresses stakeholder concerns that may adversely
affect successful program implementation.
(4) Medical support e For a new or expanded medical
program, such as NDBS, to succeed, the medical
community must accept it. Program leaders must
have sufficient knowledge and vision to address
medical questions in a manner that builds confi-
dence and collaboration among peers. Successful
NDBS requires timely and appropriate diagnosis and
treatment, which requires the cooperation of pri-
mary care and specialty healthcare providers.
(5) Technical support e Because NDBS analytical pro-
tocols are micro-techniques that differ from routine
medical laboratory tests, implementation usually
requires some technical training and knowledge
sharing. Similarly, specimen collection and trans-
port as well as the post-analytical processes of
result reporting and follow-up (including clinical
and laboratory confirmation) are essential pre-
analytical processes that must be properly
executed. Analytical technical support is often
available from product vendors specializing in
NDBS, and pre- and post-analytical support can be
obtained from other more developed NDBS
programs.
(6) Logistical support e Mechanisms must be developed
for obtaining and distributing blood collection sup-
plies, training the testing and follow-up personnel,
transporting specimens to the screening labo-
ratory(ies), providing for screening laboratory oper-
ations (equipment, supplies and maintenance),
maintaining appropriate records, and reporting the
screening results quickly while addressing cultural
and other sensitivities.
(7) Protocol/policy development e Institutionalized pol-
icies and protocols addressing all NDBS system com-
ponents prevent confusion and unnecessary overlap.
Six system components should be addressed: educa-
tion, screening (including considerations of consent/
dissent for testing, data sharing, and residual spec-
imen storage and use), follow-up/tracking, diagnosis,
treatment/management, and evaluation/quality
improvement. A comprehensive listing of possible
program elements that may be included in policy/
protocol development [Program Evaluation and
Assessment Scheme (PEAS)] has been published and
may provide a useful planning tool. [23]
(8) Administration e Strong leadership, planning and
policy development should lead to efficient and
effective program administration/management. Suc-
cessful patient outcomes will be achieved with
properly functioning program components and timely
and optimized medical management. Good programadministration should ensure that improved newborn
health is attainable within the confines of the
healthcare system.
(9) Evaluation e Outcome monitoring by observation of
disorder-specific sentinel events provides a means for
NDBS system evaluation and should be designed to
assist with continuing program improvements. Simi-
larly, indicators of the successful function of other
NDBS system components, including external labora-
tory proficiency testing, should be monitored as part
of an overall quality assurance program. The PEAS
tool noted earlier has been modified for this purpose
in at least one NDBS program [23,24].
(10) Sustainability e To become sustainable, the NDBS
system must be integrated into a functioning public
health system and be adequately financed. Some
countries have been successful in obtaining approval
for financing through national public health insur-
ance programs, but this process is often slow and
incomplete. As a result, other financing schemes,
including a fee system, should be considered. Many
developed programs implore a system in which
birthing facilities purchase screening kits (collection
cards) and are responsible for their own reim-
bursement. In such cases, care must be taken to
limit the administrative/collection charges that may
be added to the test cost to the patient; otherwise,
the patient charges will become excessive and
counterproductive. When fees are considered, all
program costs, including both laboratory and non-
laboratory screening elements (i.e., program
administration, equipment, education, public re-
lations, follow-up, and specimen storage), must be
considered [25,26].4. Elements in overcoming NBS
implementation challenges
The ten challenges previously listed have been successfully
dealt with to varying degrees in all developed and devel-
oping NDBS programs. The identification of local champions
for NDBS who are willing to spend the necessary time to
achieve successful implementation is essential to success.
In most cases, the impetus for NDBS has originated from
local champions who have learned of the importance of
screening from the experiences of other countries. The
ability of NDBS champions to obtain support from and
involvement of the health ministry directly impacts the
speed of NDBS implementation and its subsequent expan-
sion. Expert advice from both within and external to a
developing NDBS program is also essential to successful
program development. Collaborations between government
and non-government organizations (including religious
leaders) offer unique opportunities that can result in
quantifiable population health benefits. Ultimately, NDBS
must be embraced by a knowledgeable public intent on
improving child health and society, and the successful
involvement of supportive media representatives (press,
radio, television) can often assist in providing this
knowledge.
54 B.L. Therrell, C.D. Padilla4.1. Acknowledging the rights of the child
The UN Declaration of the Rights of the Child and The UN
Convention on the Rights of the Child have been particu-
larly useful for approaching government policymakers in
the developing world regarding NDBS [27,28]. Recognizing
the ‘Rights of the Child’ has often been used as part of the
argument for persuading government policymakers of their
responsibilities in providing NDBS as a preventative mea-
sure for improved newborn and child health. Both the
Marrakech and Cebu Declarations make reference to these
UN activities [3,6]. Most countries are now signatories to
the Convention, which requires signatories to “recognize
the right of the child to the enjoyment of the highest
attainable standard of health” [Art. 24(1)]. In ensuring
these rights, parties are to take appropriate measures to
“diminish infant and child mortality” [Art. 24(2a)] and to
“ensure the provision of necessary medical assistance and
healthcare to all children with emphasis on the develop-
ment of primary healthcare” [Art. 24(2)] [28].
4.2. Leveraging government resources
Often, NDBS champions are not government employees
(public servants), and their knowledge of NDBS originates
from training or research experiences in more developed
settings. In some cases, their initial intent is to establish a
small NDBS program to the benefit of a local group of pa-
tients in a limited setting, such as a private hospital of an
academic center. In developing national health systems, it
is thus not surprising to find that more than one effort may
be ongoing to establish a NDBS program. This sometimes
results in unnecessary competitions that slow the progress
of a sustainable national NDBS system.
For a national NDBS program to succeed, there ulti-
mately must be intersection with the national public health
system/health ministry. A coordinated effort that has gov-
ernment support is an important step to sustainability
because there are usually many government services and
networks that can be leveraged to the benefit of NDBS. For
example, an existing maternal and child health infrastruc-
ture within the health ministry has the potential for rapidly
spreading knowledge of NDBS activities throughout the
country (including remote areas). Nurses, clinics and other
service delivery systems that are already in place can
provide the needed logistical support, and policies and
procedures already in place may provide a foundation on
which to quickly establish the new program.
Other components of a government health system
infrastructure also have been useful in NDBS infrastructure
development. As one example, government hospitals have
provided successful models for NDBS program imple-
mentation. Their closely regulated activities offer a
convenient means for implementing program protocols in a
controlled manner, which may provide a model for other
hospitals as the program proceeds. Similarly, government
health clinics and birthing centers also may provide a
controlled environment in which to pilot screening services.
National government-run immunization programs have
provided support capabilities to some developing programs.
In programs requiring early immunization for certainconditions, such as hepatitis, immunization personnel have
sometimes collected NDBS specimens as an additional re-
sponsibility. In cases in which vaccination schedules do not
provide timely patient contact sufficient for satisfactory
NDBS, the population-based nature of most public health
immunization systems can still be useful for parent and
community education. Organized immunization programs
can provide follow-up tracking and other program assis-
tance in remote areas for newborns with positive or un-
satisfactory screening results. Some programs also have
utilized the immunization supply delivery system for logis-
tical support to provide NDBS specimen collection kits to
birthing facilities.
The government public health systems often employ
professional health educators (or other professional staff
with health educator responsibilities) and maintain public
health information offices that may provide professional
media support (the ability to produce pamphlets, posters,
videos, etc.). In cases in which such capabilities and
personnel exist, they have usually been available for a
wider range of health-related educational activities,
including NDBS. In many public health education systems,
there are material-distribution capabilities and evaluation
systems that can monitor material usage. By taking
advantage of the existing capabilities, developing or
expanding NDBS systems may quickly, efficiently and inex-
pensively provide the needed public education.
4.3. Leveraging resources from non-government
organizations (NGOs)
In addition to the benefits obtained from existing govern-
ment programs, developing NDBS systems have also been
successful in leveraging capabilities present in NGOs. Some
of the organizations that have played significant roles in
developing NDBS systems include academic institutions,
professional societies, private insurers, civic organizations,
and sectarian and religious groups. Although statements of
support from the government are essential for sustainability,
positive reinforcement from professional societies is also
useful in advancingNDBS activities. Support statements from
local organizations can be combined with those from orga-
nizations in countries that have long-standing and successful
NDBS to achieve stronger impact [29,30]. Support from and
through major academic centers are often crucial for diag-
nosing, managing and treating at-risk patients identified
through NDBS. Expertise from interested academicians has
proven useful for not only monitoring treatment and/or
compliance with treatment but also policy development and
supporting training and educational activities.
In some countries, public service organizations, such as
Lions Club International and Rotary International, have
provided funding support for various items, such as infor-
mational materials, laboratory equipment, laboratory fa-
cilities, and services for charity patients. The UN Children’s
Fund (UNICEF) has provided funding support for the pro-
duction and distribution of informational brochures on
NDBS in some developing countries. The March of Dimes
Birth Defects Foundation has assisted with financial support
for expert speakers at national and regional meetings.
Sectarian and religious groups also have been helpful in
certain populations, particularly those with beliefs that can
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sectarian and religious pre-nuptial couple’s conferences
may include mention of the value of NDBS.
4.4. Developing protocol and policy
NBDS protocol and policy development require individuals
with sufficient technical knowledge and experience to
guide a consensus-building process. Many models of suc-
cessful NDBS systems exist, and their successes should be
utilized whenever possible to avoid wasted effort in rein-
vention. Technical screening protocols are well developed
and are often available through companies that supply
laboratory supplies and through publications describing the
activities of developed programs. In contrast, NDBS pro-
gram policies in developing programs, while similar to those
in developed programs, usually require customization to
meet local needs. When creating policies, multi-
disciplinary input and consensus development are encour-
aged such that stakeholder acceptance can be maximized.
Properly developed and administered policies should
include responsibilities for program implementation and
administration at all levels of operation. It is important that
contingency planning be included in protocol and policy
development to address actions that should be taken in
cases of natural or man-made disasters [31]. Well-thought-
out contingency plans exist in some developed programs
and are available on the Internet along with instructions for
plan development [32,33].
4.5. Considering legislation
Health ministries may administer public health policy in
different manners, including proclamations, laws, policies,
administrative orders, and policy-related rules and regula-
tions. In most countries, NDBS is successfully administered
as a medical ‘best practice’, and a law requiring its
implementation is not necessary. However, in some coun-
tries, the force of a legal mandate has been necessary as an
aid to ensure universal implementation and equality. Two
developing programs, China and the Philippines, provide
examples of how legislative language has been used. In
China, Presidential Order No 33, Article 24 (1994) states
that “. medical and health institutions shall gradually
develop medical and healthcare services such as the
screening of newborn babies.” [34] In the Philippines, Re-
public Act 9288, Article 1, Section 3 (2004) states that “.
every newborn must be given access to newborn
screening”, and Article 3 states that “. any health prac-
titioner who delivers, or assists in the delivery, of a
newborn in the Philippines shall, prior to delivery, inform
the parents or legal guardian of the newborn of the avail-
ability, nature, and benefits of newborn screening” [35].
4.6. Organizing an advisory committee
Successful NDBS programs usually have an advisory com-
mittee of some type for not only advice but also professional
assistance and advocacy [7,23,36]. In addition to medical
experts, advisory committees often include members rep-
resenting professional and community groups interested inor impacted by NDBS. In this way, as program policies are
debated and developed, members of the advisory commit-
tee can become advocates in their respective disciplines. In
cases in which program managers cannot lobby policy-
makers, advisory committee members may fulfill that role.
Because the committee approach is often slow and delib-
erate, particularly when it is multi-disciplinary and the
knowledge level is low, most developing programs have
found it expeditious to use advisory groups sparingly until
the foundation for the program has been established.
4.7. Creating advocacy/public relations
The timely education of consumers, healthcare pro-
fessionals and policymakers is essential for both establish-
ing and expanding NDBS. Similarly, a well-thought-out
advocacy campaign has often been found to aid in gaining
public acceptance of a new or expanding NDBS program.
Support from the local medical/paramedical community
and medical specialists is also essential for the program to
succeed. Health professionals play a key role in educating
and motivating families and others in the community
regarding the importance of NDBS. Families, in turn, can
assist health professionals in convincing policymakers to
sustain NBS at the national level.
Successful developing programs must be creative in their
educational approaches and must be careful to be cultur-
ally sensitive and present material at a sufficiently low
educational level to meet local needs. Some programs have
found it useful to provide educational videos, books and/or
compact discs to educate various stakeholders (for
example, see information on manuals in the Philippine
NDBS program) [37]. Comic books in local languages have
been used to help educate low-literacy mothers in Mexico
and the Philippines. Posters illustrating proper specimen
collection techniques in the local languages are widely
distributed to specimen collection facilities in both devel-
oped and developing programs. For metabolic conditions
requiring special nutritional diets, cookbooks using local
food products and written in local dialects have also been
widely created and distributed.
4.8. Using expert assistance
Because NDBS programs have existed in most parts of the
developed world for 40e50 years, there are many well-
established systems from which to draw expertise. To speed
the development process, newly developing and expanding
NDBS programs are encouraged to collaborate with acknowl-
edged international experts. Experts often have been used for
the development of NDBS programs to aid program design and
present educational seminars to professionals, policymakers
and consumers. Policymakers have acknowledged the value of
information exchanges with ‘outside’ experts to add legiti-
macy to internal deliberations on NDBS. As part of the activ-
ities of the MENA NDBS conferences, participants and thyroid
NDBS experts have prepared flip chart educational materials
to use for convincing government policymakers of the impor-
tance of screening and to answer their basic questions about
program development. A reference book based on experi-
ences in the AP region has also been produced [7].
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NDBS programs have often been initiated by individuals or
groups as academic or private projects. No NDBS project has
been universally accessible and institutionalized at the na-
tional level without some support from the health ministry.
Occasionally, private entrepreneurs have begun NDBS pro-
grams in an effort to reach selected portions of the popula-
tion (usually the private pay clients), but full population
screening, including the indigent population, requires gov-
ernment support. Although health ministries are sometimes
reluctant to take the lead in implementing NDBS, their
reluctance diminishes as programs show success in reducing
childhood morbidity and mortality. For this reason and for
the fact that public policydevelopment usually requires valid
supporting data, pilot screening projects are usually neces-
sary. These projects should be focused on statistically valid
case detection projections in limited settings that can be
completed in comparatively short periods of time. Reaching
adequate health ministry support requires political aware-
ness and perseverance. As examples, NBS programs in the
Philippines, Egypt, Qatar and United Arab Emirates, among
others, now have full government support. Although
coverage in the latter three countries is essentially 100%,
government support in the Philippines is relatively recent,
and coverage expanded from 5.2% to 30% in its first five years
as part of the public health system [3,35,38].
4.10. Gaining health professional and hospital
support
With beginning NDBS programs, it is important to have
support from general physicians, pediatricians, obstetri-
cians, and specialty care providers to both educate parents
and meet the medical needs of a newborn and its family.
Because births most often occur in hospitals, it is also
necessary to have support from the hospitals’ administra-
tion. Experience has shown that these stakeholders most
often desire information on the history of NDBS, rationales
for its existence, benefits to individual newborns, families
and society, financial strategies, and future plans. The goal
of transferring this knowledge is to make every healthcare
practitioner and hospital administrator into passionate ad-
vocates for the NDBS program. Some programs have found
that simple performance rewards for reaching program
milestones are effective for obtaining individual participa-
tion and support. For example, inexpensive but tasteful
recognition plaques and framed certificates have been
periodically presented to hospital administrators and phy-
sicians to acknowledge their contributions to increased
newborn screening acceptance and coverage. Contests
(with appropriate prizes) encouraging advocacy through
posters in hospital waiting areas and banners outside of
hospitals have been successful for increasing program use.
Billboards have also been used to advertise the importance
of NBS, and videotaped advocacy and information messages
have been widely used in hospital waiting areas [39,40].
4.11. Media
Multi-pronged media campaigns have proven extremely
useful for accelerating community support for NDBS indeveloping health systems. Most of the population is
accessible through various public media, i.e., radio, tele-
vision and newspaper. For this reason, advocates of
developing health systems have successfully used oppor-
tunities to explain NDBS on television and radio talk shows.
Public service announcements and magazine and news-
paper articles have also been shown to be successful public
relations strategies. Although health professionals are
often useful for explaining the medical implications of
NDBS, parents are important for explaining the real impact
of screening from a personal and family perspective. It is
particularly impactful when contrasting cases can be illus-
trated (i.e., one child with a condition detected and suc-
cessfully treated as a result of screening versus one who
was affected with the condition as a result of not having
been screened). The media have also played roles in
tracking down patients for follow-up in situations in which
it was difficult to locate a family following a positive
screening test. Smartphone technologies are providing
additional capabilities for NDBS education and tracking.
4.12. Maintaining records
Lessons learned from and models of developed NDBS pro-
grams provide a wealth of materials from which developing
NBS programs can profit. One such example involves the
creation and maintenance of records. It is essential that
accurate records be kept regarding the offering of screening
tests, their results, and subsequent related activities.
Furthermore, these results must be carefully controlled
such that patient and family privacy is protected. A number
of models exist pertaining to computerized record keeping,
including examples of integrated systems that allow access
to other health records, such as immunizations and birth
records. Integrated systems allow the utilization of other
programs as an aid to tracking and compliance monitoring
[41,42]. For example, integrated data between NDBS and
immunizations can allow confirmation of screening at the
time of immunization such that infants who have not been
screened may be provided the service. Similarly, birth cer-
tificates can be used to record a NDBS kit number for use in
compliance monitoring [43]. To simplify electronic health
records in the U.S., the Library of Medicine is currently
creating a computerized coding and language infrastructure
to aid in the standardization of electronic records and result
transfer, and this may ultimately prove beneficial for future
NDBS systems outside of the U.S. [44].
The residual blood that remains on the NDBS specimen
card following screening is another type of record that re-
quires consideration. These unique specimens have the
potential to generate population-based information that
could have significant health benefits. These specimens
contain extractable DNA from a newborn who has not yet
been subjected to environmental factors. Whether these
specimens are stored for research beyond newborn
screening is a subject for extended debate at the program
policy level. All NDBS programs are encouraged to consider
this topic and develop a realistic policy for the storage and
use of residual specimens [45e47]. If stored, the governing
policy should promote public trust. The program must
assure that the confidentiality and privacy of families is
respected and that the specimens are protected.
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It is important to note that the U.S. Association of State and
Territorial Public Health Officials (ASTHO) has recently
recognized NDBS as a “core” public health function [48].
The Centers for Disease Control and Prevention (CDC) has
also listed newborn screening expansion as one of the “Ten
Great Public Health Achievements in the U.S. from 2001 to
2010.” [49] The formal recognition and institutionalization
of NDBS as a public health prevention program is a critical
step in implementing and sustaining NBS. To be sustainable,
NDBS must exist as a six-part comprehensive system, and
each component must be carefully considered in its insti-
tutionalization [1].
The timely recall of patients identified as ‘at increased
risk’ for disorders identified through screening is one of the
most challenging parts of the NDBS system. Most NDBS pro-
grams, whether developed or developing, acknowledge that
the location of patients who were screened as positive is
severely impacted by the inability of the system to maintain
accurate information of the patients’ addresses and the
failure of parents to identify a physician who will serve as
the newborn’s primary care provider following discharge
from the newborn nursery. Public health clinics and
outreach programs in developing and developed health sys-
tems have provided an important means for contacting pa-
tients who were screened as positive in both rural and urban
settings. In the urban environment, government clinics and
government hospitals have provided follow-up clinical and
laboratory services as part of the NDBS system. In rural
areas, public health nurses, local clinics, and an informal
health network have assisted with difficult follow-up cases.
As systems mature, it becomes increasingly feasible to
establish regional follow-up centers that can provide
comprehensive follow-up care, including genetic counseling.
Specialty care (i.e., pediatric endocrinologists, pediatric
hematologists, and metabolic physicians) must be available
and accessible to assist with proper clinical diagnoses and
patient management. Such specialty care is often limited in
developing settings and may be available only in one or two
locations. There may be limited availability in both the
public and private sectors. In locations in which specialty
providers are not readily available, it may be necessary to
rely on a physician with a special interest in a particular
disorder who may be knowledgeable but is not a trained
specialist. Telehealth is an increasing priority in both
developed and developing healthcare settings and, in some
cases, may prove useful for NDBS specialty care.
The availability of specialty care treatment supplies in
developing countries may also prove challenging. Medical
foods, formulas, and pharmaceuticals may be difficult to
routinely obtain or expensive. Suppliers outside of the
country may be necessary for initiating and sustaining some
of the treatments for certain screened conditions, in which
cases cordial relationships with supplier representatives
may prove beneficial. Parent advocates in developed
countries have also assisted in providing limited supplies
and drawing attention to national needs.
Once an NDBS program has been implemented,
continuing education should be a priority. Human resources
are limited and may preclude the extended training of largenumbers of workers. Workshops that provide education in a
‘train the trainer’ mode have been found to be an efficient
and effective model. For example, the IAEA sponsored
regional workshops in the AP region to train laboratory
specialists in testing procedures for congenital hypothyroid
screening. Similar types of workshops were held for pro-
gram administrators and follow-up coordinators [50]. This
model has been effectively used in both developed and
developing NDBS systems. The Japanese International
Cooperation Agency (JICA) also has provided basic educa-
tion and training with ongoing support to developing NBS
programs, including many in both the MENA and AP regions
[51]. Many educational resources are available from
developed and more mature developing programs, and
immature developing programs have found it prudent to
supplement their training activities with these materials
(videotapes, various books and pamphlets, and protocols).
Once training materials are developed locally, it is a simple
matter to update and redistribute them periodically.
Specimen transport and test result communications have
required special attention in many developing programs.
Local mail delivery systems are often not reliable and
cannot be used for specimen transport. Additionally, some
of the screening tests may require rapid specimen delivery
(1e2 days) such that analyses and results are available in
time for interventions to be medically successful (some-
times within five days after birth). It therefore becomes
necessary to work locally with organizations that specialize
in transport services to develop usable systems. In some
cases, special shipping arrangements have been made with
couriers, bus companies, air delivery services, and private
postal services. In climates where heat and humidity may
compromise specimen integrity, transport in air-
conditioned vehicles or special packaging may be
required. The screening test results must also be available
in a timely manner, and positive results are usually re-
ported by telephone, telefax, or other rapid special tele-
communication arrangements. Due to the difficulty
associated with finding patients, the communication of test
results requiring immediate (emergency) follow-up have
sometimes required the involvement of government police
and media announcements to locate families. In at least
one case in a remote area, the local taxi company was
aware of the family’s location and was used to assist in
locating the child for follow-up.
6. Financing
Ideally, the financial sustainability of NDBS programs re-
quires full government support. However, because of other
competing health priorities, full government support of
NDBS is usually not possible. As a result, almost all NDBS
programs face financing challenges. Out of necessity,
developing NDBS programs have been particularly innova-
tive in approaching financing. Often, small grants have
been used for initial planning and pilot testing, but this has
not been practical for the long term. In some developing
programs, initial screening services have been paid for
through small fees paid by the family or other benefactors.
Unfortunately, there is extensive poverty in many countries
where NDBS is developing, and small fees may appear to
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usually substantially less than those of other prenatal
medical services and are bargains compared with other
healthcare costs.
Once implemented, NDBS is usually viewed as a routine
health necessity, and most programs (developed and
developing) plan ways to ensure that screening is accessible
to the entire newborn population, regardless of their ability
to pay. As a matter of equitable healthcare delivery, NDBS
planning should include financial support for those who
cannot pay. To offset screening fees (where they exist),
some programs, most notably the Philippines, have devel-
oped model financing strategies and educational programs
to encourage parents to save for this expense [35]. In some
cases, altruistic organizations and local governments have
provided financial assistance through gifts or loans to lower
or eliminate costs. To be totally sustainable at the national
level, NBS must ultimately be part of government and pri-
vate insurance.
Adequate program funding is essential, and considerable
time and effort should thus be expended in developing
appropriate costing data and planning program finances. If
fees are necessary, a sound billing and collection system
must exist, and the fee must be comprehensive (i.e., it
must include the items necessary for sustainability e edu-
cation, screening, and follow-up). Two primary monetary
flow mechanisms exist: (1) direct billing to the birthing
facility following testing and (2) billing for NBS collection
cards purchased prior to screening. The former requires the
program to front its costs to recover expenses after the
fact, whereas the latter allows advance payment. Both
systems have been used in developed and developing pro-
grams. In cases in which government funds pay for the
program, the costs must also be carefully documented, and
a sound mechanism for receiving and spending funds must
exist. In either case, a sound accounting system and careful
record keeping are required.
7. Program quality
The importance of high-quality screening services cannot
be overstated. Public confidence and confidence from the
medical community rely on the assumption that screening
results are valid and indicate increased risk when positive
screening results are reported and a lack of risk when
negative screening results are reported. An internal quality
assurance program, coupled with periodic external evalu-
ation and laboratory proficiency testing, has been effective
in meeting most NDBS program needs. Laboratory quality
management has generally utilized assay controls and
standards supplied by the reagent kit manufacturers and
external proficiency testing from various sources, such as
the U.S. CDC [52e54]. Diagnostic laboratories are also part
of the NDBS system and should be included in quality con-
siderations. Non-laboratory components of the NDBS system
are equally important, and an active self-evaluation system
is encouraged. The U.S. PEAS provides a comprehensive
evaluation model that has been translated into Persian and
Chinese, and has been modified for evaluation of the three
separate components of the Philippine NDBS program
[23,24].8. Conclusions
Continuing emphasis on improving the health of mothers
and children and an expanding knowledge of the success of
NDBS in reducing morbidity and mortality in newborns have
led to increased interest in initiating NDBS programs in
developing healthcare systems. This interest has been
particularly evident in the MENA and AP regions, where
NDBS Champions have successfully begun screening in over
30 countries in recent years. Varied experiences exist
within both regions as a result of the population hetero-
geneity, health ministry priorities, poverty, geography,
politics, and other factors affecting the development of
sustainable NDBS programs. Regional meetings in both the
MENA and AP regions have led to commitments to increase
screening activities that were formalized in the Marrakech
and Cebu Declarations, respectively [3,6]. These declara-
tions provided a valuable first step toward the imple-
mentation and sustainment of NDBS programs in countries
in both regions. To date, a limited number of countries in
the MENA and AP regions report the existence of universally
available national NDBS programs that screen for at least
one condition, although many limited coverage screening
projects exist. In several countries with and without na-
tional coverage, multiple conditions are screened. Various
implementation strategies, including collaborations with
countries outside of the respective regions as a means of
obtaining start-up laboratory and administrative support,
have been employed. In successful screening programs in
Qatar, Lebanon, Laos and the Philippines, the start-up ac-
tivities involved sending specimens to developed screening
laboratories in Germany and Australia [35,38,55,56].
Although most programs have focused on initial
screening for congenital hypothyroidism, which is known to
be cost-effective in most screening settings, tandem mass
spectrometry (MS/MS) for metabolic conditions has also
been embraced by some developing programs. Although
MS/MS screening is relatively expensive and technically
challenging, its use in screening for metabolic conditions in
countries where consanguinity leads to increased incidence
of metabolic conditions will likely prove to be cost-
effective. Ongoing MS/MS studies in Lebanon, Qatar, and
Saudi Arabia should provide useful information for coun-
tries in the MENA region, and similarly, data from projects
in China, Japan, and other countries should provide infor-
mation for the large AP screening population
[2,38,55,57,58].
In addition to the regional meetings noted in this
manuscript, other international collaborations have pro-
vided opportunities for expanding knowledge and meeting
the other challenges encountered when establishing and
strengthening NDBS programs. Although it is no longer a
viable funding source, the IAEA provided start-up assistance
(technical training and administrative support) for
congenital hypothyroidism screening in many MENA and AP
countries [6,50]. Similarly, JICA has provided (and con-
tinues to provide) NDBS training courses for developing
programs in the MENA and AP regions in addition to selected
programs in Latin America [51]. Initiatives from commercial
vendors have provided innovative purchasing strategies and
pricing for reagents and equipment that have encouraged
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grams continue to contribute both time and energy to
training and transferring knowledge to developing pro-
grams. Progressive health ministry officials overseeing
developing healthcare systems have provided support in
some countries, and their interest appears to be increasing
(as their knowledge increases), indicating that more na-
tional NDBS programs may profit from ministry support in
the near future.
In the future, expanding communication technologies will
likely play a larger role in educating parents andprofessionals
regarding NDBS. In developing healthcare systems, commu-
nication technologies should be particularly useful for data
and result transfer and for improved vendor support of testing
equipment and other supplies critical to the screening pro-
cess. Strategic planning as well as multi-national collabora-
tionswill continue tobe critical to sustainableNBS.Necessary
information for policy decisions originate from data, and it is
important that national and regional data be standardized,
collected centrally and periodically analyzed. Programs
should be aware of developing international information
technology standards and definitions such that they may be
considered during planning deliberations. New technologies
continue to be developed to result in an increased number of
screening possibilities, and efforts must be made in devel-
oping programs to stay abreast of technological changes that
may affect screening protocols and policies.
In this manuscript, we have attempted to outline some
of the ways in which NDBS programs are meeting the system
development challenges faced in developing health sys-
tems. Institutionalizing NDBS for a single condition in
countries with little or no previous newborn screening ac-
tivity or expanding to meet the growing health needs in
others requires dedication and perseverance. Leaders in
establishing NDBS programs must provide health ministries
with sufficient knowledge and understanding to gain their
support if the programs are to become sustainable at the
national level.Conflict of Interest
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